<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JHC</journal-id>
<journal-id journal-id-type="hwp">spjhc</journal-id>
<journal-title>Journal of Histochemistry &amp; Cytochemistry</journal-title>
<issn pub-type="ppub">0022-1554</issn>
<issn pub-type="epub">1551-5044</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1369/0022155412459857</article-id>
<article-id pub-id-type="publisher-id">10.1369_0022155412459857</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Iduronic Acid in Chondroitin/Dermatan Sulfate</article-title>
<subtitle>Biosynthesis and Biological Function</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western"><surname>Malmström</surname><given-names>Anders</given-names></name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western"><surname>Bartolini</surname><given-names>Barbara</given-names></name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western"><surname>Thelin</surname><given-names>Martin A.</given-names></name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western"><surname>Pacheco</surname><given-names>Benny</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western"><surname>Maccarana</surname><given-names>Marco</given-names></name>
</contrib>
<aff id="aff1-0022155412459857">Department of Experimental Medical Science, Biomedical Center D12, Lund University, Lund, Sweden</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0022155412459857">Marco Maccarana, Department of Experimental Medical Science, Biomedical Center D12, Lund University, SE-221 84 Lund, Sweden. E-mail <email xlink:type="simple">marco.maccarana@med.lu.se</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2012</year>
</pub-date>
<volume>60</volume>
<issue>12</issue>
<fpage>916</fpage>
<lpage>925</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>7</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>8</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">The Histochemical Society</copyright-holder>
</permissions>
<abstract>
<p>The ability of chondroitin/dermatan sulfate (CS/DS) to convey biological information is enriched by the presence of iduronic acid. DS-epimerases 1 and 2 (DS-epi1 and 2), in conjunction with DS-4-O-sulfotransferase 1, are the enzymes responsible for iduronic acid biosynthesis and will be the major focus of this review. CS/DS proteoglycans (CS/DS-PGs) are ubiquitously found in connective tissues, basement membranes, and cell surfaces or are stored intracellularly. Such wide distribution reflects the variety of biological roles in which they are involved, from extracellular matrix organization to regulation of processes such as proliferation, migration, adhesion, and differentiation. They play roles in inflammation, angiogenesis, coagulation, immunity, and wound healing. Such versatility is achieved thanks to their variable composition, both in terms of protein core and the fine structure of the CS/DS chains. Excellent reviews have been published on the collective and individual functions of each CS/DS-PG. This short review presents the biosynthesis and functions of iduronic acid-containing structures, also as revealed by the analysis of the DS-epi1- and 2-deficient mouse models.</p>
</abstract>
<kwd-group>
<kwd>chondroitin sulfate</kwd>
<kwd>CS/DS proteoglycans</kwd>
<kwd>dermatan sulfate</kwd>
<kwd>dermatan sulfate epimerase 1 and 2</kwd>
<kwd>dermatan sulfate 4-O-sulfotransferase 1</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022155412459857">
<title>Structure and Biosynthesis of Chondroitin/Dermatan Sulfate</title>
<p>Chondroitin (CS) is a long, linear acidic polysaccharide consisting of the repeating disaccharide unit -4GlcAβ1–3GalNAcβ1- (<xref ref-type="bibr" rid="bibr54-0022155412459857">Silbert and Sugumaran 2002</xref>). During assembly, dermatan sulfate (DS) can be generated via epimerization of glucuronic acid (GlcA) into iduronic acid (IdoA) by two DS-epimerases (DS-epi1 and DS-epi2). Subsequently, O-sulfation in various positions is carried out by specific sulfotransferases: Four add a sulfate to the 4-OH position of GalNAc (C4ST1–3 and D4ST1), three are specific for sulfation on the 6-OH position of GalNAc (C6ST1/2 and GalNAc4–6ST, the latter adding a 6-O sulfate to an already 4-O–sulfated GalNAc), and a single CS2ST/UST adds a sulfate to the 2-OH position of both GlcA and IdoA. The reactions described above do not go to completion (i.e., only a fraction of available substrate is converted by a specific enzyme). Highly variable structures are therefore present in CS/DS chains (<xref ref-type="fig" rid="fig1-0022155412459857">Fig. 1</xref>). In this review, we will indicate the CS/DS structures with the nomenclature O, C, A, B, D, E and iO, iC, iA, iB, iD, iE for the iduronic-containing counterpart, respectively. However, the disaccharide structures depicted in <xref ref-type="fig" rid="fig1-0022155412459857">Fig. 1</xref> are just the building blocks of longer protein binding domains, which are usually five to eight monosaccharides long. The exact sequencing of these protein binding domains is still a major challenge and has only been successfully completed in some instances (<xref ref-type="bibr" rid="bibr31-0022155412459857">Li F et al. 2010</xref>; <xref ref-type="bibr" rid="bibr44-0022155412459857">Purushothaman et al. 2012</xref>). Noteworthy, the disulfated structures B/iB, D/iD, and E/iE, which usually constitute no more than 10% of the chains, often stand out as being part of protein binding domains in CS/DS. Presumably, their double sulfation favors protein interaction. Moreover, a single CS/DS may contain multiple protein binding domains and potentially have multiple functions. In addition to protein binding, CS/DS chains have self-adhesion properties (<xref ref-type="bibr" rid="bibr20-0022155412459857">Fransson et al. 1982</xref>).</p>
<fig id="fig1-0022155412459857" position="float">
<label>Figure 1.</label>
<caption>
<p>Structures and biosynthetic pathways of chondroitin/dermatan sulfate (CS/DS) disaccharide units. Studies on the disaccharide composition of CS/DS chains and enzyme specificities are the basis of this scheme. In iduronic acid (IdoA)-containing units, epimerization always occurs before sulfation. In disulfated structures, 2-O-sulfation follows both 4-O and 6-O sulfation, whereas 4-O sulfation precedes 6-O sulfation when a 4S, 6-di-O–sulfated unit is generated. Dotted lines indicate putative pathways because iC and iD unit formation has not been clarified yet.</p>
</caption>
<graphic alt-version="no" position="float" xlink:href="10.1369_0022155412459857-fig1.tif" xlink:type="simple"/></fig>
<p>The conversion of GlcA into IdoA is variable and can range from one IdoA residue per chain to almost 100% IdoA. The term <italic>CS/DS</italic> indicates the glucuronic/iduronic acid hybrid nature of the galactosaminoglycan chain. IdoA can be found in blocks (stretch of ≥6 IdoA residues), in alternating IdoA/GlcA structures, or as isolated IdoA interspersed in unmodified GlcA residues (<xref ref-type="fig" rid="fig2-0022155412459857">Fig. 2</xref>) (<xref ref-type="bibr" rid="bibr34-0022155412459857">Malmstrom et al. 1975</xref>; <xref ref-type="bibr" rid="bibr32-0022155412459857">Maccarana et al. 2009</xref>). High content of DS epimerases, especially of DS-epi1 in vivo, and a concomitant high content of the DS-specific 4-O-sulfotransferase D4ST1 are required for formation of IdoA blocks (<xref ref-type="bibr" rid="bibr32-0022155412459857">Maccarana et al. 2009</xref>; <xref ref-type="bibr" rid="bibr43-0022155412459857">Pacheco, Maccarana, and Malmstrom 2009</xref>; <xref ref-type="bibr" rid="bibr42-0022155412459857">Pacheco, Malmstrom, and Maccarana 2009</xref>). Indeed, DS-epi1 and D4ST1 are co-localized in the Golgi apparatus, as seen by confocal staining (unpublished observation). The distribution of IdoA governs some of the subsequent O-sulfation reactions. For instance, the IdoA blocks are never found containing 6-O-sulfated GalNAc and are instead 4-O sulfated and subsequently good substrates for the 2-O sulfation reaction, giving rise to consecutive iB structures. Downregulation of DS-epi1, DS-epi2, or D4ST1 all resulted in a reduced amount of iduronic acid blocks and iB residues. In addition, downregulation of D4ST1 using siRNA decreased the E/iE structures. The amount and distribution of IdoA within a single chain are cell/tissue specific (<xref ref-type="bibr" rid="bibr8-0022155412459857">Cheng et al. 1994</xref>). Furthermore, a cell can produce different CS/DS chains depending on the core protein. For example, human skin fibroblasts produce decorin/biglycan with 60% IdoA, mostly present in blocks, and versican with 7% IdoA, mostly as isolated residues (<xref ref-type="bibr" rid="bibr43-0022155412459857">Pacheco, Malmstrom, and Maccarana et al. 2009</xref>). Both the amount and distribution of IdoA are subjected to physiological regulation—for example, transforming growth factor (TGF)-β1 considerably decreases IdoA blocks in decorin and biglycan produced by fibroblasts (<xref ref-type="bibr" rid="bibr60-0022155412459857">Tiedemann et al. 2005</xref>).</p>
<fig id="fig2-0022155412459857" position="float">
<label>Figure 2.</label>
<caption>
<p>Hybrid structure of chondroitin/dermatan sulfate (CS/DS) and distribution of iduronic acid (IdoA). In vivo, IdoA is commonly found in clusters (IdoA blocks) or as isolated or alternating glucuronic acid (GlcA)/IdoA residues. High expression of DS-epimerases, in close collaboration with the dermatan-specific 4-O-sulfotransferase 1 (D4ST1), is necessary for IdoA block formation.</p>
</caption>
<graphic alt-version="no" position="float" xlink:href="10.1369_0022155412459857-fig2.tif" xlink:type="simple"/></fig>
</sec>
<sec id="section2-0022155412459857">
<title>DS-Epimerase 1 and 2 Structure and Catalytic Mechanism</title>
<p>Only three groups of enzymes catalyze the stereochemical inversion of the C5 carboxyl group of a hexuronic acid at the polymer level (i.e., the conversion takes place after the monosaccharide has been incorporated in the polysaccharide chain). In vertebrates, two DS epimerases and a single HS epimerase convert GlcA into IdoA, whereas in algae and some bacteria, alginate epimerases convert mannuronic into guluronic acid (<xref ref-type="bibr" rid="bibr63-0022155412459857">Valla et al. 2001</xref>). No primary sequence or three-dimensional (3D) similarities have been detected between the DS-epimerases and the HS epimerase, which therefore seem to be the result of convergent evolution. DS-epi1 is coded by the DSE gene on chromosome 6, whereas DS-epi2 is coded by the DSEL(-like) gene on chromosome 18 (<xref ref-type="bibr" rid="bibr33-0022155412459857">Maccarana et al. 2006</xref>). Interestingly, in DSE, the protein coding sequence is divided into five exons, whereas in DSEL, a single exon contains all the protein coding sequence. The two enzymes show apparent domain similarities (<xref ref-type="fig" rid="fig3-0022155412459857">Fig. 3</xref>). Both share an N-terminus epimerase domain (51% amino acid identity, identical secondary and 3D predicted structure). DS-epi1 has a C-terminal domain (amino acids 691–958), terminating with two membrane-spanning domains, whose function is currently unknown. No homolog of known structure has been found in 3D databases for this particular domain. Likewise, DS-epi2 has a central domain (amino acids 720–823, including the two transmembrane regions) with unknown function. These domains in DS-epi1 and 2 do not share sequence similarities.</p>
<fig id="fig3-0022155412459857" position="float">
<label>Figure 3.</label>
<caption>
<p>Three-dimensional structure of the DS-epi1 epimerase domain (above) and domain structure of DS-epimerases (below). A tetrasaccharide substrate is positioned in the groove formed by the two subdomains. The four N-glycosylation sites are indicated with arrows and labeled N1 to N4. The locations of signal peptides (SPs) and predicted transmembrane regions (TMs) are shown with asterisks.</p>
</caption>
<graphic alt-version="no" position="float" xlink:href="10.1369_0022155412459857-fig3.tif" xlink:type="simple"/></fig>
<p>Interestingly, to get enzymatic activity, the epimerase domain alone is not sufficient. In fact, recombinant 1–755-DS-epi1 is inactive, whereas 1–775-DS-epi1 is active (E. Tykesson, personal communication 2012). This is mirrored by the fact that 1–734-DS-epi2 is inactive, whereas the full size 1–1222-DS-epi2 is active (<xref ref-type="bibr" rid="bibr43-0022155412459857">Pacheco, Malmstrom, and Maccarana 2009</xref>). In addition, DS-epi2 has a C-terminal sulfotransferase domain homologous to several CS/DS O-sulfotransferases. Recombinant DS-epi2 indeed has detectable sulfotransferase activity (unpublished results), but the position of the added sulfate has yet to be defined. The epimerase domains of both enzymes carry four conserved N-glycans, which are required for activity (<xref ref-type="bibr" rid="bibr41-0022155412459857">Pacheco et al. 2009</xref>). Based on structural predictions, the epimerase domain of DS-epi1 can be further subdivided into an N-terminal domain composed of alpha-helices (amino acids 1–390; SCOP superfamily a.102.2) and a C-terminally located domain predominantly composed of beta-sheets (amino acids 391–690; SCOP superfamily b.30.5). Together, the two domains form a groove where the substrate is positioned during catalysis. Several HA-, HS-, CS-, and alginate-lyases show structural similarities to these two DS-epi1 domains. Modeling of DS-epi1 into the structure of heparinase II, as determined by crystal X-ray diffraction, showed conservation and striking similarities of the position of key amino acids shown to be essential in the catalytic mechanism of heparinase II. The importance of these amino acids has been validated through site-directed mutagenesis in recombinant DS-epi1. From these data, a mechanism of epimerization has been proposed where the C5 stereochemical inversion of the carboxyl group is achieved by the removal of the C5 proton from one side of the sugar followed by the readdition of another proton from the opposite side of the sugar plane. Four steps have been detailed: (1) His-450 removes the C5 proton from GlcA, and (2) the glycosidic linkage between the attacked GlcA and the GalNAc at the non-reducing side is broken by Tyr-261 with the subsequent formation of a C4–C5 double bond containing intermediate hexuronic acid. In (3), the intermediate hexuronic acid is protonated from the opposite side by His-205, and in (4), the glycosidic linkage is re-created by an unidentified residue. Steps 1 and 2 are in common with the mechanism of lyases, whereas subsequent steps 3 and 4 are DS-epimerase specific. In summary, due to structural similarities and catalytic mechanism, the two DS epimerases appear to have evolved from bacterial lyases.</p>
</sec>
<sec id="section3-0022155412459857">
<title>Dermatan Sulfate Epimerase 1- and 2-Deficient Mice</title>
<p>DS-epi1- and 2-deficient mouse models have been generated, and the double DS-epi1/2 KO mouse, which should be a DS-null model, is under way (<xref ref-type="bibr" rid="bibr32-0022155412459857">Maccarana et al. 2009</xref>; <xref ref-type="bibr" rid="bibr4-0022155412459857">Bartolini et al. 2012</xref>). DS-epi1 and -2 are ubiquitously expressed in the body (<xref ref-type="bibr" rid="bibr40-0022155412459857">Nakao et al. 2000</xref>; <xref ref-type="bibr" rid="bibr21-0022155412459857">Goossens et al. 2003</xref>). Brain has the lowest expression of DS-epi1 and the highest expression of DS-epi2. DS-epi1 is the major epimerase in vivo and contributes to the major part of enzyme activity in extracts of most tissues. Ablation of DS-epi1 led to an approximate 80% reduction of IdoA in the entire animal. This reduction affected both decorin chains (73% reduction in skin decorin) and versican chains (89% reduction in skin versican). DS-epi1 is mainly responsible for the biosynthesis of the iduronic acid blocks, which decreased 90% in DS-epi1-deficient mice. A remaining single functional allele of DS-epi1 (i.e., in the condition of heterozygosity) results in half of the total protein amount and enzyme activity but interestingly leaves the CS/DS structure unaltered. DS-epi2 is the major epimerase in brain, accounting for approximately 90% of the epimerase activity. These data are in agreement with in situ hybridization expression patterns in the developing mouse brain (<xref ref-type="bibr" rid="bibr2-0022155412459857">Akatsu et al. 2011</xref>). Nevertheless, brains in DS-epi2-deficient mice had a consistent, but not a dramatic, 38% reduction of IdoA in CS/DS, which in wild-type mice accounts for only 2% of total hexuronic acid residues. No phenotype in unchallenged DS-epi2-deficient mice could be observed, and brain extracellular matrix (ECM) features were normal. It thus remains to be explained why there are two DS-epimerases.</p>
<p>Although no apparent phenotype could be observed in DS-epi2-deficient mice, the phenotypes observed in DS-epi1-deficient mice are multiple. Mice lacking DS-epi1 having a mixed C57BL6/Sv129 genetic background were vital and fertile (<xref ref-type="bibr" rid="bibr32-0022155412459857">Maccarana et al. 2009</xref>). However, in pure C57BL6 background, they died at a late stage of embryonic development and perinatally (unpublished observation), and in a pure NFR genetic background, 21% of them presented a birth defect called gastroschisis, consisting of a protrusion of the abdominal content due to a defect in the abdominal wall closure (R. Gustafsson, personal communication 2012). These mice are smaller, with a lower body weight at birth compared with wild-type littermates, and this phenotype persists in adulthood. This condition becomes aggravated when DS-epi2 is also inactivated (unpublished results). DS-epi1-deficient mice have a defect in skin collagen fibril formation, leading to skin fragility. This finding links the presence of high IdoA content in skin decorin CS/DS with its capacity to modulate collagen fibrils and deepens the previous knowledge implicating the decorin proteoglycan (<xref ref-type="bibr" rid="bibr11-0022155412459857">Danielson et al. 1997</xref>) and its CS/DS chain (<xref ref-type="bibr" rid="bibr47-0022155412459857">Ruhland et al. 2007</xref>) in this function. Also, iB structures, which decrease 70% in DS-epi1-deficient skin decorin, could take part in this function. Interactions between antiparallel CS/DS chains carried by two decorins bound to adjacent collagen fibrils could be altered in DS-epi1-deficient skin (<xref ref-type="bibr" rid="bibr49-0022155412459857">Scott 1991</xref>). Another phenotype observed in DS-epi1-deficient mice is the alteration of the epidermal basement membrane, as seen by electron microscopy (S. Kalamajski, personal communication 2012). There is an abnormal distance between the basement membrane, which appears more convoluted, and the keratinocyte cellular membrane. This phenotype is reminiscent of alterations observed in the dermal-epidermal basement membrane of double nidogen-1 and 2-deficient mice (<xref ref-type="bibr" rid="bibr36-0022155412459857">Mokkapati et al. 2008</xref>). Possibly linked to the altered basement membrane, the epidermal basal layer is also thicker (R. Gustafsson, personal communication 2012).</p>
</sec>
<sec id="section4-0022155412459857">
<title>Genetic Diseases Related to DS-Specific Enzymes</title>
<p>A recently discovered genetic defect in the D4ST1 gene has been identified in 20 patients with a new type of Ehlers–Danlos syndrome (<xref ref-type="bibr" rid="bibr71-0022155412459857">Zhang et al. 2010</xref>). The disorder affects various connective tissues and is the result of impaired assembly of collagen fibrils. The main features are joint dislocations and deformities, skin hyperextensibility and fragility, and recurrent large subcutaneous hematomas. The mutations lead to a loss of D4ST1 activity, and decorin produced by affected fibroblasts was devoid of IdoA (<xref ref-type="bibr" rid="bibr35-0022155412459857">Miyake et al. 2010</xref>). Not surprisingly, given the fact that D4ST1 and the DS-epimerases are functionally closely linked in the biosynthesis of the IdoA blocks, the DS-epi1-deficient mouse presents similar defects in collagen fibril formation.</p>
<p>Also DS-epi2 could be the cause of a human disease. In fact, single-nucleotide polymorphism variants of DS-epi2 could be detected at very low frequency in a group of patients with type II bipolar disorder but not in the control group (<xref ref-type="bibr" rid="bibr21-0022155412459857">Goossens et al. 2003</xref>).</p>
</sec>
<sec id="section5-0022155412459857">
<title>Functions of Iduronic Acid in CS/DS Proteoglycans</title>
<p><xref ref-type="table" rid="table1-0022155412459857">Table 1</xref> lists 29 CS/DS-PGs, 19 of which have not been analyzed in detail for the presence of IdoA. For instance, in studies of CS/DS in the nervous system, most research has analyzed only total CS/DS extracted from whole tissue and not from individual PGs. Further work comprising single PG purification and identification with specific antibodies followed by analysis of its chains with multiple chondroitinase ABC, AC, and B digestions is required.</p>
<table-wrap id="table1-0022155412459857" position="float">
<label>Table 1.</label>
<caption>
<p>CS/DS-PGs</p>
</caption>
<graphic alt-version="no" alternate-form-of="table1-0022155412459857" position="float" xlink:href="10.1369_0022155412459857-table1.tif" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
</colgroup>
<thead>
<tr>
<th colspan="1" rowspan="1"/>
<th align="center" colspan="1" rowspan="1">PG<sup><xref ref-type="table-fn" rid="table-fn2-0022155412459857">a</xref></sup></th>
<th align="center" colspan="1" rowspan="1">IdoA</th>
<th align="center" colspan="1" rowspan="1">Functions of PG</th>
<th align="center" colspan="1" rowspan="1">CS/DS-bound Proteins Functions of CS/DS (CS/DS Units Involved)<sup><xref ref-type="table-fn" rid="table-fn3-0022155412459857">b</xref></sup></th>
<th align="center" colspan="1" rowspan="1">Reference<sup><xref ref-type="table-fn" rid="table-fn4-0022155412459857">c</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="4" valign="top">BM or BM- connected</td>
<td colspan="1" rowspan="1">Perlecan</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">BM stability, embryogenesis, FGF-2, TGF-β, PDGF regulator</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr10-0022155412459857">Couchman et al. 1996</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bamacan</td>
<td colspan="1" rowspan="1">NA<sup><xref ref-type="table-fn" rid="table-fn5-0022155412459857">d</xref></sup></td>
<td colspan="1" rowspan="1">BM stability, morphogenesis</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr24-0022155412459857">Iozzo and Clark 1986</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Leprecan</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">BM stability, collagen assembly</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr66-0022155412459857">Wassenhove-McCarthy and McCarthy 1999</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Collagen XV</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">BM organization</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr30-0022155412459857">Li D et al. 2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="5" valign="top">Nervous system</td>
<td colspan="1" rowspan="1">Neurocan</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Neurite outgrowth, growth factors binding, brain ECM organization</td>
<td colspan="1" rowspan="1">N-CAM, HB-GAM, amphoterin</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr46-0022155412459857">Rauch et al. 1991</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Phosphacan</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Neurite outgrowth, growth factors binding, brain ECM organization and differentiation</td>
<td colspan="1" rowspan="1">HB-GAM, amphoterin, midkine (B, E)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr17-0022155412459857">Faissner et al. 1994</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Brevican</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Neurite outgrowth modulation, cell adhesion and motility, brain ECM maintenance</td>
<td colspan="1" rowspan="1">Neuritogenic activity (E)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr69-0022155412459857">Yamada H et al. 1994</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Appican (AβPP isofom)</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Neuronal cell adhesion and migration, neurite outgrowth</td>
<td colspan="1" rowspan="1">Midkine, pleiotrophin</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr52-0022155412459857">Shioi et al. 1995</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Neuroglycan C</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Cerebral development, neuritogenesis</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr53-0022155412459857">Shuo et al. 2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="5" valign="top">Extracellular space</td>
<td colspan="1" rowspan="1">Aggrecan</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Cartilage weight bearing</td>
<td colspan="1" rowspan="1">Water retention (ratio C/A)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr26-0022155412459857">Kokenyesi and Silbert 1997</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Versican</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Cell adhesion, migration, proliferation, differentiation</td>
<td colspan="1" rowspan="1">FGF family, L- and P-selectin, chemokines (iE)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr25-0022155412459857">Kawashima et al. 2000</xref>; <xref ref-type="bibr" rid="bibr32-0022155412459857">Maccarana et al. 2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Decorin</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Differentiation, collagen fibrillogenesis, proliferation and wound healing, migration, coagulation, growth factors binding</td>
<td colspan="1" rowspan="1">FGF-2, FGF-7 (iA), HGF/SF (iA), HCII (iB),VWF (A/iA, C/iC, E/iE), α2β1, tenascin-X, fibril formation (iA blocks)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr12-0022155412459857">Deakin et al. 2009</xref>; <xref ref-type="bibr" rid="bibr16-0022155412459857">Elefteriou et al. 2001</xref>; <xref ref-type="bibr" rid="bibr22-0022155412459857">Guidetti et al. 2004</xref>; <xref ref-type="bibr" rid="bibr32-0022155412459857">Maccarana et al. 2009</xref>; <xref ref-type="bibr" rid="bibr61-0022155412459857">Tollefsen 2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Biglycan</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">ECM assembly, differentiation, collagen fibrillogenesis, growth factors binding</td>
<td colspan="1" rowspan="1">HCII (iB), FGF family (iA)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr23-0022155412459857">Hou et al. 2007</xref>; <xref ref-type="bibr" rid="bibr56-0022155412459857">Stocker et al. 1991</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Epiphycan</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Chondrocyte differentiation, cartilage stability</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr50-0022155412459857">Shinomura et al. 1983</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="8" valign="top">Cell surface</td>
<td colspan="1" rowspan="1">NG2</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Differentiation, proliferation and motility, PDGF-AA and FGF-2 binding, adhesion</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr55-0022155412459857">Stallcup 2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Betaglycan</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">TGF-β co-receptor, growth factor reservoir</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr3-0022155412459857">Andres et al. 1991</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Syndecan-1</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Adhesion, growth factors co-receptor</td>
<td colspan="1" rowspan="1">Midkine, pleiotrophin, FGF-7</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr29-0022155412459857">Lee et al. 2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Syndecan-3</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Adhesion, growth factors co-receptor, neurite outgrowth</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr39-0022155412459857">Nakanishi et al. 1997</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Syndecan-4</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Adhesion, growth factors co-receptor</td>
<td colspan="1" rowspan="1">Midkine, pleiotrophin</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr13-0022155412459857">Deepa et al. 2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">CD44</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Adhesion, migration</td>
<td colspan="1" rowspan="1">Migration</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr9-0022155412459857">Clark et al. 2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Neuropilin-1</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Axonal guidance, angiogenesis</td>
<td colspan="1" rowspan="1">VEGF signaling</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr51-0022155412459857">Shintani et al. 2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">α5β1</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Fibronectin-dependent cell migration, focal adhesion</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr19-0022155412459857">Franco et al. 2009</xref>; <xref ref-type="bibr" rid="bibr64-0022155412459857">Veiga et al. 1997</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="4" valign="top">Others</td>
<td colspan="1" rowspan="1">SRPX2</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Cell signaling modulation, endothelial cell migration and angiogenesis</td>
<td colspan="1" rowspan="1">HGF</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr57-0022155412459857">Tanaka et al. 2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Serglycin</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Inflammatory reaction, storage of chemokines, cytokines and proteases, mast cell secretion</td>
<td colspan="1" rowspan="1">Maturation of granules (B, E)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr27-0022155412459857">Kolset and Pejler 2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Endocan</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Mitogenic regulator, inflammation</td>
<td colspan="1" rowspan="1">HGF/SF (iA)</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr5-0022155412459857">Bechard et al. 2001</xref>; <xref ref-type="bibr" rid="bibr48-0022155412459857">Sarrazin et al. 2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Testican-1</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Inhibition of proteases, neurite extension</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr6-0022155412459857">Bonnet et al. 1992</xref>; <xref ref-type="bibr" rid="bibr15-0022155412459857">Edgell et al. 2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="2" valign="top">Collagens</td>
<td colspan="1" rowspan="1">Collagen IX</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Biomechanical stability of cartilage</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr7-0022155412459857">Bruckner et al. 1985</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Collagen XII and XIV</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Stability of cartilage and skin</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1"><xref ref-type="bibr" rid="bibr67-0022155412459857">Watt et al. 1992</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0022155412459857"><p>BM, basement membrane; CS/DS, chondroitin/dermatan sulfate; ECM, extracellular matrix; FGF, fibroblast growth factor; HB-GAM, heparin-binding growth-associated molecule; HCII, heparin cofactor II; HGF/SF, hepatocyte growth factor/scatter factor; IdoA, iduronic acid; NA, not analyzed; N-CAM, neural cell adhesion molecule; PDGF, platelet-derived growth factor; PG, proteoglycan; TGF-β, transforming growth factor–β; VEGF, vascular endothelial growth factor; VWF, von Willebrand factor.</p></fn>
<fn id="table-fn2-0022155412459857">
<label>a</label>
<p>Some are part-time CS/DS-PGs because they can be unglycanated or carry HS chains. The division in groups is arbitrary because some CS/DS-PGs can belong to more than one group.</p></fn>
<fn id="table-fn3-0022155412459857">
<label>b</label>
<p>For the symbols of the units, refer to <xref ref-type="fig" rid="fig1-0022155412459857">Figure 1</xref>.</p></fn>
<fn id="table-fn4-0022155412459857">
<label>c</label>
<p>Each PG has a reference reporting the experimental evidence of CS or eventually the CS/DS chain.</p></fn>
<fn id="table-fn5-0022155412459857">
<label>d</label>
<p>Indirect evidence was reported.</p></fn>
</table-wrap-foot></table-wrap>
<p>One classic way through which CS/DS-PGs can regulate biological processes at or near the cell surface is their ability to bind several growth factors. The flexibility of iduronic acid, which can be found as <sup>1</sup>C<sub>4</sub> and <sup>4</sup>C<sub>1</sub> chairs and <sup>2</sup>S<sub>0</sub> skew-boat conformers as opposed to GlcA found only in <sup>4</sup>C<sub>1</sub> chair conformation (<xref ref-type="bibr" rid="bibr18-0022155412459857">Ferro et al. 1990</xref>), is thought to facilitate protein binding. For instance, hepatocyte growth factor/scatter factor (HGF/SC) requires IdoA residue flanked by sulfated hexosamine (<xref ref-type="bibr" rid="bibr12-0022155412459857">Deakin et al. 2009</xref>). IdoA-containing domains have also been shown to interact with the fibroblast growth factor (FGF) family, thereby regulating wound healing and cell migration (<xref ref-type="bibr" rid="bibr62-0022155412459857">Trowbridge and Gallo 2002</xref>).</p>
<p>Basement membrane CS/DS-PGs mainly regulate the architecture of the structure they are part of. There is no clear evidence of IdoA presence in these PGs.</p>
<p>In brain, the abundant CS/DS-PGs regulate plasticity during development and regeneration after injury. Most of the described CS/DS-PGs interact with specific brain molecules of the tenascin family, midkine, pleiotrophin, and neural cell adhesion molecules, in addition to growth factors (<xref ref-type="bibr" rid="bibr70-0022155412459857">Yamada and Sugahara 2008</xref>).</p>
<p>The representative CS/DS-PG secreted in the extracellular space is decorin. It regulates collagen fibril formation and acts as a growth factor reservoir and as an anticoagulant factor, thanks to the ability of its CS/DS chain to interact with von Willebrand factor (VWF) (<xref ref-type="bibr" rid="bibr22-0022155412459857">Guidetti et al. 2004</xref>) and with heparin cofactor II (HCII), the latter via iB structures (<xref ref-type="bibr" rid="bibr61-0022155412459857">Tollefsen 2010</xref>). Decorin is therefore believed to be part of a complex acting at the subendothelial matrix regulating the clotting cascade and platelet activation.</p>
<p>The cell membrane CS/DS-PGs are co-receptors for several growth factors, and because of their transmembrane localization, they are involved in adhesion to substrates, migration, and intracellular signaling by connecting the outside environment with intracellular responses. IdoA presence is documented for CD44 after PDGF stimulation (<xref ref-type="bibr" rid="bibr9-0022155412459857">Clark et al. 2004</xref>) and for syndecan-1 produced by fibroblasts grown on a 3D collagen I gel and during in vivo wound healing (<xref ref-type="bibr" rid="bibr29-0022155412459857">Lee et al. 2004</xref>).</p>
<p>Endocan and SRPX2 have been recently described as IdoA-containing PGs. They show different functions, although they have been both connected with tumor progression. Endocan is a soluble PG bearing a single CS/DS chain expressed by vascular endothelium and released in the bloodstream. It is capable of binding HGF/SF via the CS/DS chain (<xref ref-type="bibr" rid="bibr5-0022155412459857">Bechard et al. 2001</xref>), regulating the mitogenic activity of cells. In a recent work, its chains have been analyzed both by NMR and by chondroitinase ACI split products, showing 30% of IdoA present as isolated or two to four consecutive residues (<xref ref-type="bibr" rid="bibr48-0022155412459857">Sarrazin et al. 2010</xref>). SRPX2 is upregulated in gastric cancer cells and affects cell adhesion, migration, and angiogenesis, and its IdoA content is evident given the partial digestion with chondroitinase B (<xref ref-type="bibr" rid="bibr57-0022155412459857">Tanaka et al. 2012</xref>).</p>
<p>Finally, some members of the collagen family can also be decorated with CS/DS chains, although so far they are described as CS-PGs since a proper analysis for IdoA content is lacking. Collagen XV connects the basement membrane with underlying structures, and skin collagen XII and XIV have been described in specialized sites called anchoring plaques that stabilize the cohesion between the upper dermis and the basement membrane zone (<xref ref-type="bibr" rid="bibr1-0022155412459857">Agarwal et al. 2012</xref>).</p>
</sec>
<sec id="section6-0022155412459857">
<title>Dermatan Sulfate and Cancer</title>
<p>CS/DS proteoglycans have been extensively studied in cancer (<xref ref-type="bibr" rid="bibr68-0022155412459857">Wegrowski and Maquart 2006</xref>). Focus in the past years has been on the role of the cancer stroma whose structure affects proliferation and migration of tumor cells (<xref ref-type="bibr" rid="bibr38-0022155412459857">Mueller and Fusenig 2004</xref>). There are several mechanisms through which CS/DS could influence tumor biology, among which are cell proliferation and migration via binding of growth factors (<xref ref-type="bibr" rid="bibr65-0022155412459857">Villena and Brandan 2004</xref>; <xref ref-type="bibr" rid="bibr58-0022155412459857">Taylor et al. 2005</xref>; <xref ref-type="bibr" rid="bibr45-0022155412459857">Radek et al. 2009</xref>) and hiding cancer cells from T-cell cytotoxic surveillance in blood through a selectin-mediated coating by platelets (<xref ref-type="bibr" rid="bibr28-0022155412459857">Kozlowski et al. 2011</xref>), to mention a few. Cell surface CS/DS-PGs on human metastatic breast cancer cell lines have been suggested as receptors for P-selectin (<xref ref-type="bibr" rid="bibr37-0022155412459857">Monzavi-Karbassi et al. 2007</xref>). Furthermore, removal of CS/DS chains by chondroitinase B has been shown to inhibit endothelial and melanoma proliferation and invasion (<xref ref-type="bibr" rid="bibr14-0022155412459857">Denholm et al. 2001</xref>). DS-epi1 has been found upregulated in almost all cancers examined (<xref ref-type="bibr" rid="bibr40-0022155412459857">Nakao et al. 2000</xref>). In a recent study, the hypothesis that IdoA-carrying proteoglycans affect tumorigenesis was directly tested (<xref ref-type="bibr" rid="bibr59-0022155412459857">Thelin et al. 2012</xref>). DS-epi1 was downregulated in the esophageal cancer cell line TE-1. The consequent 80% to 90% reduction in IdoA in CS/DS chains hampered cellular invasion and migration. This effect was pronounced in the presence of hepatocyte growth factor (HGF) and mediated through the c-Met receptor. Moreover, DS-epi1-downregulated TE-1 cells have malfunctioning assembly of adhesion complexes and abnormal cytoskeleton architecture. In conclusion, iduronic acid in esophageal cancer cells is important for invasion, migration, and signaling through the c-Met receptor.</p>
</sec>
<sec id="section7-0022155412459857">
<title>Future Directions</title>
<p>Biosynthesis of CS/DS still awaits the answer to several basic questions: How is the machinery producing structurally diverse chains controlled? Does it exist as a single macromolecular biosynthetic complex, or are there several specialized biosynthetic workstations made up of a few biosynthetic enzymes (e.g., DS-epi1 with D4ST1) to make the iduronic acid blocks? Where in the Golgi does the CS/DS biosynthesis take place? How does the core protein govern the variable structure of CS/DS chains? Which transcriptional/translational (and posttranslational) controls are exerted on the biosynthetic enzymes? Which proteoglycans contain iduronic acid? The answer to the latter question would also help to explain the largely unexplored phenotype of the DS-epi1-deficient mouse and the even more profound effect of the double ablation of DS-epi1 and -2. In fact, these models run longitudinally across the functions of each single CS/DS-PG. Finally, can the biological effects of iduronic acid be pharmacologically modulated by inhibition of DS-specific enzymes? For sure, future research on such a basic life component as CS/DS will surprise curious minds for years to come.</p>
</sec>
</body>
<back>
<ack><p>We thank Renata Gustafsson, Sebastian Kalamajski, and Emil Tykesson for sharing their unpublished observations; Giacomo Frati for helping with <xref ref-type="fig" rid="fig1-0022155412459857">Fig. 1</xref>; and Åke Oldberg for critical reading of the manuscript.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Swedish Science Research Council; the Medical Faculty of Lund University; the Greta and Johan Kock, the Albert Österlund, the Anna-Greta Crafoord to [B.B.] foundations; the Mizutani Foundation for Glycoscience to [M.M. and A.M.].</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Agarwal</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Zwolanek</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Keene</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Schulz</surname><given-names>JN</given-names></name>
<name name-style="western"><surname>Blumbach</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Heinegard</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Zaucke</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Paulsson</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Krieg</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Koch</surname><given-names>M</given-names></name>
<etal/></person-group>. <year>2012</year>. <article-title>Collagen XII and XIV—new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure</article-title>. <source>J Biol Chem</source>. <volume>287</volume>:<fpage>22549</fpage>–<lpage>22559</lpage>.</citation>
</ref>
<ref id="bibr2-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Akatsu</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Mizumoto</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kaneiwa</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Yamada</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sugahara</surname><given-names>K</given-names></name>
</person-group>. <year>2011</year>. <article-title>Dermatan sulfate epimerase 2 is the predominant isozyme in the formation of the chondroitin sulfate/dermatan sulfate hybrid structure in postnatal developing mouse brain</article-title>. <source>Glycobiology</source>. <volume>21</volume>:<fpage>565</fpage>–<lpage>574</lpage>.</citation>
</ref>
<ref id="bibr3-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Andres</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Ronnstrand</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Cheifetz</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Massague</surname><given-names>J</given-names></name>
</person-group>. <year>1991</year>. <article-title>Purification of the transforming growth factor–beta (TGF-beta) binding proteoglycan betaglycan</article-title>. <source>J Biol Chem</source>. <volume>266</volume>:<fpage>23282</fpage>–<lpage>23287</lpage>.</citation>
</ref>
<ref id="bibr4-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Bartolini</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Thelin</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Rauch</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Feinstein</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Oldberg</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
</person-group>. <year>2012</year>. <article-title>Mouse development is not obviously affected by the absence of dermatan sulfate epimerase 2 in spite of a modified brain dermatan sulfate composition</article-title>. <source>Glycobiology</source>. <volume>22</volume>:<fpage>1007</fpage>–<lpage>1016</lpage>.</citation>
</ref>
<ref id="bibr5-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Bechard</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Gentina</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Delehedde</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Scherpereel</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lyon</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Aumercier</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Vazeux</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Richet</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Degand</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Jude</surname><given-names>B</given-names></name>
<etal/></person-group>. <year>2001</year>. <article-title>Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity</article-title>. <source>J Biol Chem</source>. <volume>276</volume>:<fpage>48341</fpage>–<lpage>48349</lpage>.</citation>
</ref>
<ref id="bibr6-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Bonnet</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Perin</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Maillet</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Jolles</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Alliel</surname><given-names>PM</given-names></name>
</person-group>. <year>1992</year>. <article-title>Characterization of a human seminal plasma glycosaminoglycan-bearing polypeptide</article-title>. <source>Biochem J</source>. <volume>288</volume>(<issue>Pt 2</issue>):<fpage>565</fpage>–<lpage>569</lpage>.</citation>
</ref>
<ref id="bibr7-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Bruckner</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Vaughan</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Winterhalter</surname><given-names>KH</given-names></name>
</person-group>. <year>1985</year>. <article-title>Type IX collagen from sternal cartilage of chicken embryo contains covalently bound glycosaminoglycans</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>82</volume>:<fpage>2608</fpage>–<lpage>2612</lpage>.</citation>
</ref>
<ref id="bibr8-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Cheng</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Heinegard</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Schmidtchen</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Yoshida</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Fransson</surname><given-names>LA</given-names></name>
</person-group>. <year>1994</year>. <article-title>Patterns of uronosyl epimerization and 4-/6-O-sulphation in chondroitin/dermatan sulphate from decorin and biglycan of various bovine tissues</article-title>. <source>Glycobiology</source>. <volume>4</volume>:<fpage>685</fpage>–<lpage>696</lpage>.</citation>
</ref>
<ref id="bibr9-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Clark</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Greiling</surname><given-names>D</given-names></name>
<name name-style="western"><surname>An</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Couchman</surname><given-names>JR</given-names></name>
</person-group>. <year>2004</year>. <article-title>Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan</article-title>. <source>J Invest Dermatol</source>. <volume>122</volume>:<fpage>266</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr10-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Couchman</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Kapoor</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Sthanam</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wu</surname><given-names>RR</given-names></name>
</person-group>. <year>1996</year>. <article-title>Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix</article-title>. <source>J Biol Chem</source>. <volume>271</volume>:<fpage>9595</fpage>–<lpage>9602</lpage>.</citation>
</ref>
<ref id="bibr11-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Danielson</surname><given-names>KG</given-names></name>
<name name-style="western"><surname>Baribault</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Holmes</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>Graham</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Kadler</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>Iozzo</surname><given-names>RV</given-names></name>
</person-group>. <year>1997</year>. <article-title>Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility</article-title>. <source>J Cell Biol</source>. <volume>136</volume>:<fpage>729</fpage>–<lpage>743</lpage>.</citation>
</ref>
<ref id="bibr12-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Deakin</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Blaum</surname><given-names>BS</given-names></name>
<name name-style="western"><surname>Gallagher</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Uhrin</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Lyon</surname><given-names>M</given-names></name>
</person-group>. <year>2009</year>. <article-title>The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns</article-title>. <source>J Biol Chem</source>. <volume>284</volume>:<fpage>6311</fpage>–<lpage>6321</lpage>.</citation>
</ref>
<ref id="bibr13-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Deepa</surname><given-names>SS</given-names></name>
<name name-style="western"><surname>Yamada</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Zako</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Goldberger</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Sugahara</surname><given-names>K</given-names></name>
</person-group>. <year>2004</year>. <article-title>Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors: a novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor</article-title>. <source>J Biol Chem</source>. <volume>279</volume>:<fpage>37368</fpage>–<lpage>37376</lpage>.</citation>
</ref>
<ref id="bibr14-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Denholm</surname><given-names>EM</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>YQ</given-names></name>
<name name-style="western"><surname>Silver</surname><given-names>PJ</given-names></name>
</person-group>. <year>2001</year>. <article-title>Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion</article-title>. <source>Eur J Pharmacol</source>. <volume>416</volume>:<fpage>213</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr15-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Edgell</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>BaSalamah</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Marr</surname><given-names>HS</given-names></name>
</person-group>. <year>2004</year>. <article-title>Testican-1: a differentially expressed proteoglycan with protease inhibiting activities</article-title>. <source>Int Rev Cytol</source>. <volume>236</volume>:<fpage>101</fpage>–<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr16-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Elefteriou</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Exposito</surname><given-names>JY</given-names></name>
<name name-style="western"><surname>Garrone</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Lethias</surname><given-names>C</given-names></name>
</person-group>. <year>2001</year>. <article-title>Binding of tenascin-X to decorin</article-title>. <source>FEBS Lett</source>. <volume>495</volume>:<fpage>44</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr17-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Faissner</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Clement</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lochter</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Streit</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Mandl</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>1994</year>. <article-title>Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties</article-title>. <source>J Cell Biol</source>. <volume>126</volume>:<fpage>783</fpage>–<lpage>799</lpage>.</citation>
</ref>
<ref id="bibr18-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Ferro</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Provasoli</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Ragazzi</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Casu</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Torri</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Bossennec</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Perly</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Sinay</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Petitou</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Choay</surname><given-names>J</given-names></name>
</person-group>. <year>1990</year>. <article-title>Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences</article-title>. <source>Carbohydr Res</source>. <volume>195</volume>:<fpage>157</fpage>–<lpage>167</lpage>.</citation>
</ref>
<ref id="bibr19-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Franco</surname><given-names>CR</given-names></name>
<name name-style="western"><surname>Trindade</surname><given-names>ES</given-names></name>
<name name-style="western"><surname>Rocha</surname><given-names>HA</given-names></name>
<name name-style="western"><surname>da Silveira</surname><given-names>RB</given-names></name>
<name name-style="western"><surname>Paludo</surname><given-names>KS</given-names></name>
<name name-style="western"><surname>Chammas</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Veiga</surname><given-names>SS</given-names></name>
<name name-style="western"><surname>Nader</surname><given-names>HB</given-names></name>
<name name-style="western"><surname>Dietrich</surname><given-names>CP</given-names></name>
</person-group>. <year>2009</year>. <article-title>Glycosaminoglycan chains from alpha5beta1 integrin are involved in fibronectin-dependent cell migration</article-title>. <source>Biochem Cell Biol</source>. <volume>87</volume>:<fpage>677</fpage>–<lpage>686</lpage>.</citation>
</ref>
<ref id="bibr20-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Fransson</surname><given-names>LA</given-names></name>
<name name-style="western"><surname>Coster</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Sheehan</surname><given-names>JK</given-names></name>
</person-group>. <year>1982</year>. <article-title>Self-association of scleral proteodermatan sulfate: evidence for interaction via the dermatan sulfate side chains</article-title>. <source>J Biol Chem</source>. <volume>257</volume>:<fpage>6333</fpage>–<lpage>6338</lpage>.</citation>
</ref>
<ref id="bibr21-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Goossens</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Van Gestel</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Claes</surname><given-names>S</given-names></name>
<name name-style="western"><surname>De Rijk</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Souery</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Massat</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Van den Bossche</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Backhovens</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Mendlewicz</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Van Broeckhoven</surname><given-names>C</given-names></name>
<etal/></person-group>. <year>2003</year>. <article-title>A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder</article-title>. <source>Mol Psychiatry</source>. <volume>8</volume>:<fpage>83</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr22-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Guidetti</surname><given-names>GF</given-names></name>
<name name-style="western"><surname>Bartolini</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Bernardi</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Tira</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Berndt</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Balduini</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Torti</surname><given-names>M</given-names></name>
</person-group>. <year>2004</year>. <article-title>Binding of von Willebrand factor to the small proteoglycan decorin</article-title>. <source>FEBS Lett</source>. <volume>574</volume>:<fpage>95</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr23-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Hou</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Min</surname><given-names>TH</given-names></name>
<name name-style="western"><surname>Strate</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Pera</surname><given-names>EM</given-names></name>
</person-group>. <year>2007</year>. <article-title>The secreted serine protease xHtrA1 stimulates long-range FGF signaling in the early <italic>Xenopus</italic> embryo</article-title>. <source>Dev Cell</source>. <volume>13</volume>:<fpage>226</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr24-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Iozzo</surname><given-names>RV</given-names></name>
<name name-style="western"><surname>Clark</surname><given-names>CC</given-names></name>
</person-group>. <year>1986</year>. <article-title>Biosynthesis of proteoglycans by rat embryo parietal yolk sacs in organ culture</article-title>. <source>J Biol Chem</source>. <volume>261</volume>:<fpage>6658</fpage>–<lpage>6669</lpage>.</citation>
</ref>
<ref id="bibr25-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Kawashima</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Hirose</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hirose</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Nagakubo</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Plaas</surname><given-names>AH</given-names></name>
<name name-style="western"><surname>Miyasaka</surname><given-names>M</given-names></name>
</person-group>. <year>2000</year>. <article-title>Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44</article-title>. <source>J Biol Chem</source>. <volume>275</volume>:<fpage>35448</fpage>–<lpage>35456</lpage>.</citation>
</ref>
<ref id="bibr26-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Kokenyesi</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Silbert</surname><given-names>JE</given-names></name>
</person-group>. <year>1997</year>. <article-title>Immortalized, cloned mouse chondrocytic cells (MC615) produce three different matrix proteoglycans with core-protein-specific chondroitin/dermatan sulphate structures</article-title>. <source>Biochem J</source>. <volume>327</volume>(<issue>Pt 3</issue>):<fpage>831</fpage>–<lpage>839</lpage>.</citation>
</ref>
<ref id="bibr27-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Kolset</surname><given-names>SO</given-names></name>
<name name-style="western"><surname>Pejler</surname><given-names>G</given-names></name>
</person-group>. <year>2011</year>. <article-title>Serglycin: a structural and functional chameleon with wide impact on immune cells</article-title>. <source>J Immunol</source>. <volume>187</volume>:<fpage>4927</fpage>–<lpage>4933</lpage>.</citation>
</ref>
<ref id="bibr28-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Kozlowski</surname><given-names>EO</given-names></name>
<name name-style="western"><surname>Pavao</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Borsig</surname><given-names>L</given-names></name>
</person-group>. <year>2011</year>. <article-title>Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin</article-title>. <source>J Thromb Haemost</source>. <volume>9</volume>:<fpage>1807</fpage>–<lpage>1815</lpage>.</citation>
</ref>
<ref id="bibr29-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Lee</surname><given-names>PH</given-names></name>
<name name-style="western"><surname>Trowbridge</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Taylor</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Morhenn</surname><given-names>VB</given-names></name>
<name name-style="western"><surname>Gallo</surname><given-names>RL</given-names></name>
</person-group>. <year>2004</year>. <article-title>Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment</article-title>. <source>J Biol Chem</source>. <volume>279</volume>:<fpage>48640</fpage>–<lpage>48646</lpage>.</citation>
</ref>
<ref id="bibr30-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Clark</surname><given-names>CC</given-names></name>
<name name-style="western"><surname>Myers</surname><given-names>JC</given-names></name>
</person-group>. <year>2000</year>. <article-title>Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells</article-title>. <source>J Biol Chem</source>. <volume>275</volume>:<fpage>22339</fpage>–<lpage>22347</lpage>.</citation>
</ref>
<ref id="bibr31-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Nandini</surname><given-names>CD</given-names></name>
<name name-style="western"><surname>Hattori</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Bao</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Murayama</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Fukushima</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Sugahara</surname><given-names>K</given-names></name>
</person-group>. <year>2010</year>. <article-title>Structure of pleiotrophin- and hepatocyte growth factor-binding sulfated hexasaccharide determined by biochemical and computational approaches</article-title>. <source>J Biol Chem</source>. <volume>285</volume>:<fpage>27673</fpage>–<lpage>27685</lpage>.</citation>
</ref>
<ref id="bibr32-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kalamajski</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kongsgaard</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Magnusson</surname><given-names>SP</given-names></name>
<name name-style="western"><surname>Oldberg</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
</person-group>. <year>2009</year>. <article-title>Dermatan sulfate epimerase 1–deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin</article-title>. <source>Mol Cell Biol</source>. <volume>29</volume>:<fpage>5517</fpage>–<lpage>5528</lpage>.</citation>
</ref>
<ref id="bibr33-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Olander</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Tiedemann</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Aebersold</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Lindahl</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
</person-group>. <year>2006</year>. <article-title>Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2</article-title>. <source>J Biol Chem</source>. <volume>281</volume>:<fpage>11560</fpage>–<lpage>11568</lpage>.</citation>
</ref>
<ref id="bibr34-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Carlstedt</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Aberg</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Fransson</surname><given-names>LA</given-names></name>
</person-group>. <year>1975</year>. <article-title>The copolymeric structure of dermatan sulphate produced by cultured human fibroblasts: different distribution of iduronic acid and glucuronic acid–containing units in soluble and cell-associated glycans</article-title>. <source>Biochem J</source>. <volume>151</volume>:<fpage>477</fpage>–<lpage>489</lpage>.</citation>
</ref>
<ref id="bibr35-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Miyake</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kosho</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Mizumoto</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Furuichi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Hatamochi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Nagashima</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Arai</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Kawamura</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Wakui</surname><given-names>K</given-names></name>
<etal/></person-group>. <year>2010</year>. <article-title>Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome</article-title>. <source>Hum Mutat</source>. <volume>31</volume>:<fpage>966</fpage>–<lpage>974</lpage>.</citation>
</ref>
<ref id="bibr36-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Mokkapati</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Baranowsky</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Mirancea</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Smyth</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Breitkreutz</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Nischt</surname><given-names>R</given-names></name>
</person-group>. <year>2008</year>. <article-title>Basement membranes in skin are differently affected by lack of nidogen 1 and 2</article-title>. <source>J Invest Dermatol</source>. <volume>128</volume>:<fpage>2259</fpage>–<lpage>2267</lpage>.</citation>
</ref>
<ref id="bibr37-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Monzavi-Karbassi</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Stanley</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Hennings</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Jousheghany</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Artaud</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Shaaf</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kieber-Emmons</surname><given-names>T</given-names></name>
</person-group>. <year>2007</year>. <article-title>Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines</article-title>. <source>Int J Cancer</source>. <volume>120</volume>:<fpage>1179</fpage>–<lpage>1191</lpage>.</citation>
</ref>
<ref id="bibr38-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Mueller</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Fusenig</surname><given-names>NE</given-names></name>
</person-group>. <year>2004</year>. <article-title>Friends or foes—bipolar effects of the tumour stroma in cancer</article-title>. <source>Nat Rev Cancer</source>. <volume>4</volume>:<fpage>839</fpage>–<lpage>849</lpage>.</citation>
</ref>
<ref id="bibr39-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Nakanishi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Kadomatsu</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Okamoto</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Ichihara-Tanaka</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Kojima</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Saito</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Tomoda</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Muramatsu</surname><given-names>T</given-names></name>
</person-group>. <year>1997</year>. <article-title>Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine</article-title>. <source>J Biochem</source>. <volume>121</volume>:<fpage>197</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr40-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Nakao</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Shichijo</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Imaizumi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Inoue</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Matsunaga</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Yamada</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Kikuchi</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Tsuda</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Ohta</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Takamori</surname><given-names>S</given-names></name>
<etal/></person-group>. <year>2000</year>. <article-title>Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL</article-title>. <source>J Immunol</source>. <volume>164</volume>:<fpage>2565</fpage>–<lpage>2574</lpage>.</citation>
</ref>
<ref id="bibr41-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Pacheco</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Goodlett</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>L</given-names></name>
</person-group>. <year>2009</year>. <article-title>Identification of the active site of DS-epimerase 1 and requirement of N-glycosylation for enzyme function</article-title>. <source>J Biol Chem</source>. <volume>284</volume>:<fpage>1741</fpage>–<lpage>1747</lpage>.</citation>
</ref>
<ref id="bibr42-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Pacheco</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
</person-group>. <year>2009</year>. <article-title>Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of iduronic acid blocks in dermatan sulfate</article-title>. <source>Glycobiology</source>. <volume>19</volume>:<fpage>1197</fpage>–<lpage>1203</lpage>.</citation>
</ref>
<ref id="bibr43-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Pacheco</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
</person-group>. <year>2009</year>. <article-title>Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate</article-title>. <source>J Biol Chem</source>. <volume>284</volume>:<fpage>9788</fpage>–<lpage>9795</lpage>.</citation>
</ref>
<ref id="bibr44-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Purushothaman</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Sugahara</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Faissner</surname><given-names>A</given-names></name>
</person-group>. <year>2012</year>. <article-title>Chondroitin sulfate “wobble motifs” modulate maintenance and differentiation of neural stem cells and their progeny</article-title>. <source>J Biol Chem</source>. <volume>287</volume>:<fpage>2935</fpage>–<lpage>2942</lpage>.</citation>
</ref>
<ref id="bibr45-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Radek</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Taylor</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Gallo</surname><given-names>RL</given-names></name>
</person-group>. <year>2009</year>. <article-title>FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation</article-title>. <source>Wound Repair Regen</source>. <volume>17</volume>:<fpage>118</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr46-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Rauch</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Gao</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Janetzko</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Flaccus</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Hilgenberg</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Tekotte</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Margolis</surname><given-names>RK</given-names></name>
<name name-style="western"><surname>Margolis</surname><given-names>RU</given-names></name>
</person-group>. <year>1991</year>. <article-title>Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies</article-title>. <source>J Biol Chem</source>. <volume>266</volume>:<fpage>14785</fpage>–<lpage>14801</lpage>.</citation>
</ref>
<ref id="bibr47-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Ruhland</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Schonherr</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Robenek</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Hansen</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Iozzo</surname><given-names>RV</given-names></name>
<name name-style="western"><surname>Bruckner</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Seidler</surname><given-names>DG</given-names></name>
</person-group>. <year>2007</year>. <article-title>The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis</article-title>. <source>FEBS J</source>. <volume>274</volume>:<fpage>4246</fpage>–<lpage>4255</lpage>.</citation>
</ref>
<ref id="bibr48-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Sarrazin</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lyon</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Deakin</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Guerrini</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Lassalle</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Delehedde</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Lortat-Jacob</surname><given-names>H</given-names></name>
</person-group>. <year>2010</year>. <article-title>Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan</article-title>. <source>Glycobiology</source>. <volume>20</volume>:<fpage>1380</fpage>–<lpage>1388</lpage>.</citation>
</ref>
<ref id="bibr49-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Scott</surname><given-names>JE</given-names></name>
</person-group>. <year>1991</year>. <article-title>Proteoglycan: collagen interactions in connective tissues: ultrastructural, biochemical, functional and evolutionary aspects</article-title>. <source>Int J Biol Macromol</source>. <volume>13</volume>:<fpage>157</fpage>–<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr50-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Shinomura</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Kimata</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Oike</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Noro</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Hirose</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Tanabe</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Suzuki</surname><given-names>S</given-names></name>
</person-group>. <year>1983</year>. <article-title>The occurrence of three different proteoglycan species in chick embryo cartilage: isolation and characterization of a second proteoglycan (PG-Lb) and its precursor form</article-title>. <source>J Biol Chem</source>. <volume>258</volume>:<fpage>9314</fpage>–<lpage>9322</lpage>.</citation>
</ref>
<ref id="bibr51-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Shintani</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Takashima</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Asano</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kato</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Liao</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Yamazaki</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tsukamoto</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Seguchi</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Fukushima</surname><given-names>T</given-names></name>
<etal/></person-group>. <year>2006</year>. <article-title>Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling</article-title>. <source>EMBO J</source>. <volume>25</volume>:<fpage>3045</fpage>–<lpage>3055</lpage>.</citation>
</ref>
<ref id="bibr52-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Shioi</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Pangalos</surname><given-names>MN</given-names></name>
<name name-style="western"><surname>Ripellino</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Vassilacopoulou</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Mytilineou</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Margolis</surname><given-names>RU</given-names></name>
<name name-style="western"><surname>Robakis</surname><given-names>NK</given-names></name>
</person-group>. <year>1995</year>. <article-title>The Alzheimer amyloid precursor proteoglycan (appican) is present in brain and is produced by astrocytes but not by neurons in primary neural cultures</article-title>. <source>J Biol Chem</source>. <volume>270</volume>:<fpage>11839</fpage>–<lpage>11844</lpage>.</citation>
</ref>
<ref id="bibr53-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Shuo</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Aono</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Matsui</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Tokita</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Maeda</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Shimada</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Oohira</surname><given-names>A</given-names></name>
</person-group>. <year>2004</year>. <article-title>Developmental changes in the biochemical and immunological characters of the carbohydrate moiety of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan</article-title>. <source>Glycoconj J</source>. <volume>20</volume>:<fpage>267</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr54-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Silbert</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Sugumaran</surname><given-names>G</given-names></name>
</person-group>. <year>2002</year>. <article-title>Biosynthesis of chondroitin/dermatan sulfate</article-title>. <source>IUBMB Life</source>. <volume>54</volume>:<fpage>177</fpage>–<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr55-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Stallcup</surname><given-names>WB</given-names></name>
</person-group>. <year>2002</year>. <article-title>The NG2 proteoglycan: past insights and future prospects</article-title>. <source>J Neurocytol</source>. <volume>31</volume>:<fpage>423</fpage>–<lpage>435</lpage>.</citation>
</ref>
<ref id="bibr56-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Stocker</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Meyer</surname><given-names>HE</given-names></name>
<name name-style="western"><surname>Wagener</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Greiling</surname><given-names>H</given-names></name>
</person-group>. <year>1991</year>. <article-title>Purification and N-terminal amino acid sequence of a chondroitin sulphate/dermatan sulphate proteoglycan isolated from intima/media preparations of human aorta</article-title>. <source>Biochem J</source>. <volume>274</volume>(<issue>Pt 2</issue>):<fpage>415</fpage>–<lpage>420</lpage>.</citation>
</ref>
<ref id="bibr57-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Tanaka</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Arao</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Tamura</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Aomatsu</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Furuta</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Matsumoto</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Kaneda</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Kudo</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Fujita</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kimura</surname><given-names>H</given-names></name>
<etal/></person-group>. <year>2012</year>. <article-title>SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancer</article-title>. <source>PLoS One</source>. <volume>7</volume>:<fpage>e27922</fpage>.</citation>
</ref>
<ref id="bibr58-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Taylor</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Rudisill</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Gallo</surname><given-names>RL</given-names></name>
</person-group>. <year>2005</year>. <article-title>Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity</article-title>. <source>J Biol Chem</source>. <volume>280</volume>:<fpage>5300</fpage>–<lpage>5306</lpage>.</citation>
</ref>
<ref id="bibr59-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Thelin</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Svensson</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Shi</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Bagher</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Axelsson</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Isinger-Ekstrand</surname><given-names>A</given-names></name>
<name name-style="western"><surname>van Kuppevelt</surname><given-names>TH</given-names></name>
<name name-style="western"><surname>Johansson</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Nilbert</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Zaia</surname><given-names>J</given-names></name>
<etal/></person-group>. <year>2012</year>. <article-title>Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma</article-title>. <source>Cancer Res</source>. <volume>72</volume>:<fpage>1943</fpage>–<lpage>1952</lpage>.</citation>
</ref>
<ref id="bibr60-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Tiedemann</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Olander</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Eklund</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Todorova</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Bengtsson</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Maccarana</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Westergren-Thorsson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Malmstrom</surname><given-names>A</given-names></name>
</person-group>. <year>2005</year>. <article-title>Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes</article-title>. <source>Glycobiology</source>. <volume>15</volume>:<fpage>1277</fpage>–<lpage>1285</lpage>.</citation>
</ref>
<ref id="bibr61-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Tollefsen</surname><given-names>DM</given-names></name>
</person-group>. <year>2010</year>. <article-title>Vascular dermatan sulfate and heparin cofactor II</article-title>. <source>Prog Mol Biol Transl Sci</source>. <volume>93</volume>:<fpage>351</fpage>–<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr62-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Trowbridge</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Gallo</surname><given-names>RL</given-names></name>
</person-group>. <year>2002</year>. <article-title>Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology</article-title>. <volume>12</volume>:<fpage>117R</fpage>–<lpage>125R</lpage>.</citation>
</ref>
<ref id="bibr63-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Valla</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ertesvag</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Barbeyron</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Lindahl</surname><given-names>U</given-names></name>
</person-group>. <year>2001</year>. <article-title>Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis</article-title>. <source>Biochimie</source>. <volume>83</volume>:<fpage>819</fpage>–<lpage>830</lpage>.</citation>
</ref>
<ref id="bibr64-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Veiga</surname><given-names>SS</given-names></name>
<name name-style="western"><surname>Elias</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Gremski</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Porcionatto</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>da Silva</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Nader</surname><given-names>HB</given-names></name>
<name name-style="western"><surname>Brentani</surname><given-names>RR</given-names></name>
</person-group>. <year>1997</year>. <article-title>Post-translational modifications of alpha5beta1 integrin by glycosaminoglycan chains: the alpha5beta1 integrin is a facultative proteoglycan</article-title>. <source>J Biol Chem</source>. <volume>272</volume>:<fpage>12529</fpage>–<lpage>12535</lpage>.</citation>
</ref>
<ref id="bibr65-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Villena</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Brandan</surname><given-names>E</given-names></name>
</person-group>. <year>2004</year>. <article-title>Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration</article-title>. <source>J Cell Physiol</source>. <volume>198</volume>:<fpage>169</fpage>–<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr66-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Wassenhove-McCarthy</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>McCarthy</surname><given-names>KJ</given-names></name>
</person-group>. <year>1999</year>. <article-title>Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan</article-title>. <source>J Biol Chem</source>. <volume>274</volume>:<fpage>25004</fpage>–<lpage>25017</lpage>.</citation>
</ref>
<ref id="bibr67-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Watt</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Lunstrum</surname><given-names>GP</given-names></name>
<name name-style="western"><surname>McDonough</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Keene</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Burgeson</surname><given-names>RE</given-names></name>
<name name-style="western"><surname>Morris</surname><given-names>NP</given-names></name>
</person-group>. <year>1992</year>. <article-title>Characterization of collagen types XII and XIV from fetal bovine cartilage</article-title>. <source>J Biol Chem</source>. <volume>267</volume>:<fpage>20093</fpage>–<lpage>20099</lpage>.</citation>
</ref>
<ref id="bibr68-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Wegrowski</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Maquart</surname><given-names>FX</given-names></name>
</person-group>. <year>2006</year>. <article-title>Chondroitin sulfate proteoglycans in tumor progression</article-title>. <source>Adv Pharmacol</source>. <volume>53</volume>:<fpage>297</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr69-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Watanabe</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Shimonaka</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name>
</person-group>. <year>1994</year>. <article-title>Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family</article-title>. <source>J Biol Chem</source>. <volume>269</volume>:<fpage>10119</fpage>–<lpage>10126</lpage>.</citation>
</ref>
<ref id="bibr70-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Yamada</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sugahara</surname><given-names>K</given-names></name>
</person-group>. <year>2008</year>. <article-title>Potential therapeutic application of chondroitin sulfate/dermatan sulfate</article-title>. <source>Curr Drug Discov Technol</source>. <volume>5</volume>:<fpage>289</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr71-0022155412459857">
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Muller</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Baenziger</surname><given-names>JU</given-names></name>
<name name-style="western"><surname>Janecke</surname><given-names>AR</given-names></name>
</person-group>. <year>2010</year>. <article-title>Congenital disorders of glycosylation with emphasis on loss of dermatan-4-sulfotransferase</article-title>. <source>Prog Mol Biol Transl Sci</source>. <volume>93</volume>:<fpage>289</fpage>–<lpage>307</lpage>.</citation>
</ref></ref-list>
</back>
</article>